A critical discovery in cancer research is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This vital tumor protector protein is frequently disabled in various forms of malignancies, resulting https://bookmarkspecial.com/story22130053/nanobodies-reactivate-tumor-suppressor-p53-new-new-pathway-for-cancer-management